| Financial Year |
March 31 2023 |
| Monetary Funds |
117,739,990.43 |
| Held-for-trading Financial Assets |
12,113,881.11 |
| Notes Receivable |
-- |
| Accounts Receivable |
164,711,841.01 |
| Advances to Suppliers |
12,582,229.87 |
| Other Receivables |
6,583,311.63 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
148,124,023.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,311,328.22 |
| Total Current Assets |
468,146,606.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
101,154,141.22 |
| Investment Properties |
-- |
| Fixed Assetes |
449,960,857.99 |
| Under-construction Projects |
32,315,086.38 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
29,627,484.23 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
25,260,791.87 |
| Deferred Income Tax Assets |
18,588,312.15 |
| Other Non-Current Assets |
106,193,271.31 |
| Sub-Total of Non-Current Assets |
1,172,518,773.22 |
| Total Assets |
1,640,665,379.48 |
| Short-Term Loans |
195,655,294.45 |
| Trading Financial liabilities |
-- |
| Notes Payable |
57,774,742.87 |
| Accounts Payable |
100,988,292.39 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
31,062,393.80 |
| Taxes Payable |
8,535,770.64 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,725,343.30 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
305,449.91 |
| Sub-Total of Current Liabilities |
411,622,911.10 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
44,741,246.15 |
| Other Non-Current Liabilities |
8,490,000.00 |
| Sub-Total of Non-Current Liabilities |
55,589,536.75 |
| Total Liabilities |
467,212,447.85 |
| Paid-In Capital(Or Share Stock) |
100,051,020.00 |
| Capital Surplus |
516,112,774.80 |
| Surplus Reserve |
45,355,874.20 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
512,683,515.13 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,173,452,931.63 |
| Owner's Equity（Stockholder's Equity） |
1,173,452,931.63 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,640,665,379.48 |
